Iron and oxidative injury - A commentary on "Fatty acid-mediated iron translocation: A synergistic mechanism of oxidative injury" by D. Yao et al.

Free Radical Biology and Medicine

Volumn 39, Issue 10, 2005, Pages 1305-1309

  Kallianpur, Asha R ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FAT; FATTY ACID; FREE RADICAL; IRON; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SATURATED FATTY ACID; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ALZHEIMER DISEASE; CANCER; CARDIOVASCULAR DISEASE; CELL METABOLISM; CONGESTIVE CARDIOMYOPATHY; DEGENERATIVE DISEASE; DIETARY INTAKE; DISEASE COURSE; DNA SYNTHESIS; ENDOSOME; FRIEDREICH ATAXIA; GENETIC DISORDER; HEMOCHROMATOSIS; HUMAN; INFLAMMATION; IRON OVERLOAD; IRON TRANSPORT; LYSOSOME STORAGE DISEASE; MITOCHONDRIAL RESPIRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; SIDEROBLASTIC ANEMIA; STROKE;

ANIMALS; BIOLOGICAL TRANSPORT; CORONARY DISEASE; FATTY ACIDS; FEMALE; HUMANS; INFLAMMATION; IRON; MICE; MITOCHONDRIA; MODELS, CHEMICAL; NEOPLASMS; OXIDANTS; OXIDATION-REDUCTION; OXIDATIVE STRESS; OXYGEN;

ATAXIA;

EID: 27544491298     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.07.014     Document Type: Note

References (40)

1. F.B. Hu, and W.C. Willett Optimal diets for prevention of coronary heart disease JAMA 288 2002 2569 2578
2. D. Mozaffarian, E.B. Rimm, and D.M. Herrington Dietary fats, carbohydrates, and progression of coronary atherosclerosis in postmenopausal women Am. J. Clin. Nutr. 80 2004 1175 1184
3. R.A. Christon Mechanisms of action of dietary fatty acids in regulating the activation of vascular endothelial cells during atherogenesis Nutr. Rev. 61 2003 272 279
4. M.A. Creager, T.F. Luscher, F. Cosentino, and J.A. Beckman Diabetes and vascular disease. Pathophysiology, clinical consequences, and medical therapy: Part I Circulation 108 2003 1527 1532
5. E.E. Blaak Fatty acid metabolism in obesity and type 2 diabetes mellitus Proc. Nutr. Soc. 62 2003 753 760
6. J.L. Sullivan Iron and the sex difference in heart disease risk Lancet 1 1981 1293 1294
7. J.T. Salonen, K. Nyyssonen, H. Korpela, J. Tuomilehto, R. Seppanen, and R. Salonen High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men Circulation 86 1992 803 811
8. R.J. Wood The iron-heart disease connection: is it dead or just hiding? Ageing Res. Rev. 3 2004 355 367
9. S.M. Day, D. Duquaine, L.V. Mundada, R.G. Menon, B.V. Khan, S. Rajagopalan, and W.P. Fay Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis Circulation 107 2003 2601 2606
10. M.C.R. Symons, and J.M.C. Gutteridge Free radicals and iron: chemistry, biology and medicine 1998 Oxford University Press London
11. F.D. Kolodgie, H.K. Gold, A.P. Burke, D.R. Fowler, H.S. Kruth, D.K. Weber, A. Farb, L.J. Guerrero, M. Hayase, R. Kutys, J. Narula, A.V. Finn, and R. Virmani Intraplaque hemorrhage and progression of coronary atheroma N. Engl. J. Med. 349 2003 2316 2325
12. G. Papanikolaou, and K. Pantopoulos Iron metabolism and toxicity Toxicol. Appl. Pharmacol. 202 2005 199 211
13. J.W. Eaton, and M. Qian Molecular bases of cellular iron toxicity Free Radic. Biol. Med. 32 2002 833 840
14. I. Napier, P. Ponka, and D.R. Richardson Iron trafficking in the mitochondrion: novel pathways revealed by disease Blood 105 2005 1867 1874
15. O. Kakhlon, and Z.I. Cabantchik The labile iron pool: characterization, measurement, and participation in cellular processes (1) Free Radic. Biol. Med. 33 2002 1037 1046
16. O. Kakhlon, Y. Gruenbaum, and Z.l. Cabantchik Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells Blood 97 2001 2863 2871
17. C. Le Lan, O. Loreal, T. Cohen, M. Ropert, H. Glickstein, F. Laine, M. Pouchard, Y. Deugnier, A. Le Treut, W. Breuer, Z.I. Cabantchik, and P. Brissot Redox-active plasma iron in C282Y/C282Y hemochromatosis Blood 105 2005 4527 4531
18. E.W. Randell, J.G. Parkes, N.F. Olivieri, and D.M. Templeton Uptake of non-transferrin-bound iron by both reductive and nonreductive processes is modulated by intracellular iron J. Biol. Chem. 269 1994 16046 16053
19. B. de Valk, M.A. Addicks, I. Gosriwatana, S. Lu, R.C. Hider, and J.J. Marx Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes Eur. J. Clin. Invest. 30 2000 248 251
20. A.R. Kallianpur, L.D. Hall, M. Yadav, B.W. Christman, R.S. Dittus, J.L. Haines, F.F. Parl, and M.L. Summar Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer Cancer Epidemiol. Biomarkers Prev. 13 2004 205 212
21. T.P. Tuomainen, K. Kontula, K. Nyyssonen, T.A. Lakka, T. Helio, and J.T. Salonen Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation: a prospective cohort study in men in eastern Finland Circulation 100 1999 1274 1279
22. M. Roest, Y.T. van der Schouw, B. de Valk, J.J. Marx, M.J. Tempelman, P.G. De Groot, J.J. Sixma, and J.D. Banga Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women Circulation 100 1999 1268 1273
23. B.P. Esposito, W. Breuer, I. Slotki, and Z.I. Cabantchik Labile iron in parenteral iron formulations and its potential for generating plasma nontransferrin-bound iron in dialysis patients Eur. J. Clin. Invest. 32 Suppl. 1 2002 42 49
24. T.A. Ikizler, J.D. Morrow, L.J. Roberts, J.A. Evanson, B. Becker, R.M. Hakim, Y. Shyr, and J. Himmelfarb Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients Clin. Nephrol. 58 2002 190 197
25. G. Nie, A.D. Sheffel, S.F. Kim, and P. Ponka Overexpression of mitochondrial ferritin causes cytosolic iron depletion and changes cellular iron homeostasis Blood 105 2005 2161 2167
26. T. Turoczi, L. Jun, G. Cordis, J.E. Morris, N. Maulik, R.G. Stevens, and D.K. Das HFE mutation and dietary iron content interact to increase ischemia/reperfusion injury of the heart in mice Circ. Res. 92 2003 1240 1246
27. M. Sulieman, R. Asleh, Z.I. Cabantchik, W. Breuer, D. Aronson, A. Sulieman, R. Miller-Lotan, H. Hammerman, and A.P. Levy Serum chelatable redox-active iron is an independent predictor of mortality after myocardial infarction in individuals with diabetes Diabetes Care 27 2004 2730 2732
28. D. Penzo, C. Tagliapietra, R. Colonna, V. Petronilli, and P. Bernardi Effects of fatty acids on mitochondria: implications for cell death Biochim. Biophys. Acta 1555 1-3 2002 160 165
29. J.E. de Vries, M.M. Vork, H.M.R. Theo, Y.F. de Jong, J.P.M. Cleutjens, G.J. van der Vusse, and M. Bilsen Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes J. Lipid Res. 38 1997 1384 1394
30. M.W. Qian, and J.W. Eaton Iron translocation by free fatty acids Am. J. Pathol. 139 1991 1425 1434
31. A.R. Kallianpur, L.D. Hall, M. Yadav, D.W. Byrne, T. Speroff, R.S. Dittus, J.L. Haines, B.W. Christman, and M.L. Summar The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation Bone Marrow Transplant. 35 12 2005 1155 1164
32. M.P. Mattson Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders Ann. N.Y. Acad. Sci. 1012 2004 37 50
33. L. Zecca, M.B. Youdin, P. Riederer, J.R. Connor, and R.R. Crichton Iron, brain ageing and neurodegenerative disorders Nat. Rev. Neurosci. 5 2004 863 873
34. V.J. Adlam, J.C. Harrison, C.M. Porteous, A.M. James, R.A. Smith, M.P. Murphy, and I.A. Sammut Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury FASEB J. 19 2005 1088 1095
35. G.M. Enns The contribution of mitochondria to common disorders Mol. Genet. Metab. 80 2003 11 26
36. Canter, J. A.; Kallianpur, A. R.; Parl, F. F.; Millikan, R. C. Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res. (in press).
37. J.M. Fernando-Real, A. Lopez-Bermejo, and W. Ricart Cross talk between iron metabolism and diabetes Diabetes 51 2002 2348 2354
38. M.H. Selim, and R.R. Ratan The role of iron neurotoxicity in ischemic stroke Ageing Res. Rev. 3 2004 345 353
39. M. Suter, C. Reme, C. Grimm, A. Wenzel, M. Jaattela, P. Esser, N. Kociok, M. Leist, and C. Richter Age-related macular degeneration: the lipofuscin component N-retinyl-N-retinylidene ethanolamine detaches proapoptotic proteins from mitochondria and induces apoptosis in mammalian retinal pigment epithelial cells J. Biol. Chem. 275 2000 39625 39630
40. Z. Guo, A. Ersoz, D.A. Butterfield, and M.P. Mattson Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function after exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid J. Neurochem. 75 2000 314 320